Mehmet Emre Atabek has completed his PhD from Erciyes University and Post-doctoral studies from Selcuk University School of Meram Medicine. He is the Director of Pediatric Endocrinology, a premier Pediatric Endocrinolgy and Diabetology service organization. He has published more than 120 papers in reputed journals and has been serving as an Editorial Board Member of repute. He has been interested in searching metabolic problems of obese children in most of his articles. His articles have been cited more than 1100 citations by another article in Web of Science so far. He continues to work as Head of the Department of Pediatric Endocrinology, Necmettin Erbakan University.

Yusha Araf is an enthusiastic and innovative individual with extensive experience in leadership, team management, event planning, social networking. This person exhibits a high level of dedication, gets fully engaged and has a clear vision of his goals. He does not get distracted and uses his energy entirely towards the manifestation of his dreams and makes full use of his resources. He fully realizes his psychological and spiritual potential. He is the founder of “Community of Biotechnology”, a national organization where all the students of biotechnology of public and private universities in Bangladesh are united in a platform where they share different resources with one another and do research despite being in different institutions. It offers workshops, seminars and research opportunity throughout the country. It is being collaborated with many well-known national and international organization in the world. He is also the founder of “Odhimatrik” and co-founder of ‘Ovilash”. He is working as a Head of Campus Representatives of YSI Bangladesh which is an international organization, head office in Norway. He is the Campus Coordinator of WHO Simulation Bangladesh. He is also working as a Campus Ambassador of Battery Low Interactive which is one of the first and foremost exponents of AR and VR technologies in Bangladesh. He is involved in the Academic Team of Bangladesh Mathematical Olympiad, Bangladesh Physics Olympiad. Bangladesh Biology Olympiad and Bangladesh Astro Olympiad. He is the mentor of ‘Alor Moshal’ where students are being coached to get admissions and scholarships in US universities. He also works in UDVASH, an educational institution where he is managing around 190 thousand students in the social media. He is the Deputy Academic and Research Director of SUST Science Arena

Douglas N. Ishii was born in a US concentration camp at the onset of WWII. B.A. Biochemistry, Univ. Calif. Berkeley; Ph.D. Pharmacology,Stanford Univ. Medical Sch.; postdoctoral fellow Neurobiology, Stanford Univ. He was Associate Prof. Pharmacology at Columbia Univ. NYC, and is a Professor of Biomedical Sciences at Colorado State Univ. He served on scientific study sections for National Science Foundation, National Institutes of Health, and the Juvenile Diabetes International Foundation. Articles on his research on pathogenesis of diabetic complications, and brain atrophy in Alzheimer’s disease, have appeared in Der Spiegel, Hong Kong Standard, NY Times, LA Times, Denver Post, ABC News, Forbes News, and USA Today.

Vladimír Štrbák has completed his study in Bratislava. He was the Director of Institute of Experimental Endocrinology- SAS, Slovakia, and the Head of Pathological Physiology, Slovak Medical University, Slovakia. He is the President of the Slovak Physiological Society, Council Member FEPS, Chair of the Scientific Board of the Slovak Academy of Sciences for Medical Sciences, and Council Member of the International Society for Pathophysiology. He has 137 published PuBMed papers. He has served as an Organizing Committee Member of the Global Diabetes Summit and Medicare Expo in Dubai (2015) and Birmingham (2016)

Doctor Marco Songini is the Director Center for the Treatment of Complications of Diabetes, San Michele Hospital Cagliari, Sardinia, Italy. Doctor Marco Songini has published over 161 papers on the subject of atherosclerosis and epidemiology of Diabetes. He is a recognized expert in the etiopathology and epidemiology of type 1 diabetes and diabetes in general. After obtaining a degree in Medicine from the University of Cagliari in 1977, he obtained his specialization in Diabetology, University of Turin (1980), his specialization in Endocrinology, University of Rome (1984) and specialization in Dietology, University of Cagliari (1988)

Dr. Yousef Shahin is a medical doctor with more than 28 years, 9 years of which as manager in Disease prevention and control programme., he joined Jordan University of Science and Technology where he obtained his Master degree in Public Health in 1996. Since 2005; he is at senior position in United Nations and Relief Agency for Palestine refuges (UNRWA), manger of communicable and non-communicable diseases programme. Since August 2015 he is working as Medical Director for Disease Management at Aetna, Qatar. He has good teaching and training experience in Public Health and related courses in Epidemiology and occupational health for both undergraduate students, medical and paramedical

Prof. Antonelli is currently Director of the Immuno-Endocrine Section of Internal Medicine and Associate Professor in the Department of Clinical and Experimental Medicine, University of Pisa, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy. He graduated in Medicine cum laude at the University of Pisa in 1982, where he received the post-graduate Specialization in Endocrinology in 1985 and in Occupational Health in 1987. He received also the postgraduate Specialization in Oncology (at the University La Sapienza, Rome, Italy) in 1992. His researches have been published in more than 260 articles on International journals

Deya has published more than 20 articles during her career on human, animal, plant and yeast research. She is a member of the Endocrine Society and acts as an expert reviewer for Journal of Clinical Endocrinology and Metabolism, Human Reproduction and others. She teaches within the Genetics & Biochemistry (College of Medicine) and Biomedical Engineering (College of Engineering) undergraduate programmes.

Udaya M Kabadi completed General Medicine residency at KEM Hospital and obtained Post-graduate degree (MD) from Mumbai University, Mumbai, India. He continued his Post-graduate training in Internal Medicine and fellowship training in New York, NY, USA. He is Board Certified in Internal Medicine, Endocrinology,Metabolism and Geriatric Medicine by American Board of Internal Medicine. He is a fellow of American College of Physicians, American College of Endocrinologyand Royal College of Physicians of Canada. He is an Adjunct Professor of Medicine at Des Moines University, Des Moines, Iowa and University of Iowa, Iowa,USA. He has authored over 190 papers in peer reviewed medical journals and 2 books. He has conducted over 500 CME presentations and chaired symposia atregional, national and international meetings. He serves as a member of Editorial Board of many medical journals. He has also been elected 'Teacher of the Year'by undergraduate students and post-graduate trainees on several occasions during his career.

Dr. Choudhery earned a BS (Hons) degree from the University of Punjab in 2007. He completed his PhD from National Center of excellence in Molecular Biology (CEMB) in 2012. He completed a part of his research work in Professor David Harris’s Laboratory at College of Medicine, Department of Immunology, The University of Arizona, Tucson, USA. Dr. Choudhery also worked as Post-doctorate Fellow at the College of Medicine, Department of Immunology, The University of Arizona, Tucson, USA. In 2012 he joined the faculty at the King Edward Medical University as an Assistant Professor. Dr. Choudhery’s research interests include clinical applications of stem cells, caloric restriction, tissue engineering, stem cell transplantation and gene therapy. Further he has a great interest in developing cell-free stem cell based therapies. He has published several research articles in peer reviewed international journals. Currently he is serving as a reviewer and editorial board member of more than 15 international Journals.

Helmy has been widely recognized for his exceptional teaching. He has been honored with the Department of Medicine Distinguished Teaching Award (1997), the Trustees Teaching Award (1998, 2000, and 2005), the General Internal Medicine/Geriatrics Division Outstanding Teacher Award (2001), the Outstanding Professor in Clinical Sciences Award (2003 and 2004), and the School of Medicine Teaching Award (2005). He is also a three-time recipient of the Outstanding Educator Award (1999, 2003, and 2006), which is given by the departing class of IU School of Medicine senior residents to the faculty member who has contributed most significantly to their education during their residency.

Dr. Vincenzo Costigliola has more than 40 years of medical practice after graduating in Medicine at the University of Naples (Italy), and a post-degree specialization in Anesthesiology and Intensive Care from the Università di Pisa (Italy).

Dr Michael Klentze graduated from medical school in Munich in 1976, and completed his Ph.D in 1984. Dr Klentze holds qualifications in Neurochemistry, Gynecology and Obstetrics, Psychiatry, Psychotherapy, Endocrinology and Diabetology.In 1996 the Klentze Institut was founded, specializing in anti-aging and regenerative medicine. In the following years Dr Michael Klentze became a sought-after speaker in aging and preventive medicine, and has continued to remain on the cutting edge of medical science with extensive involvement in stem cell and genetics applied in clinical medicine. Dr Klentze is currently the Chief Scientific and Medical Officer of the Klentze Medical Faculty, medical training company, specialising in anti-aging, preventive and regenerative medicine, and at the Thanyapura Medical Centre since 2012.Dr Klentze has held several notable positions including: Secretary General of the European Society of Preventive, Regenerative and Anti-Aging Medicine between 2003-2009

Denis Barritault graduated in Math and Physics, completed his Ph.D. in biochemistry in Paris University. Post doctoral in molecular immunology at Pasteur Institute and NYU as NIH Fogarty Fellow he joined INSERM unit in Paris as developmental biologist. He made the first description and patents of FGF extracted from retina in 1979 and 82 as skin and cornea healing agent, became full Professor at Paris East University in 1985, founded and directed a CNRS Laboratory on cell and tissue regeneration until 2003. He is now President of OTR3, Emeritus Professor and author in over 200 publications and 29 patent

Lakshmi Kant Shankhdhar is a Principal of a Medical College devoted to diabetes education. He is triply Post-graduate in Medicine (MD), Nutrition (PGDND) andRadiology (DMRE). He is also heading an exclusive private Diabetes Clinic in Lucknow, India. He has received Visiting Fellowship of Harvard Medical International,International Arm of Harvard Medical School (Boston), as Life Time Achievement Award. Currently, he is a Reviewer of two most prestigious journals of Diabetes,namely Diabetes Care and Diabetes. He has presented several abstracts and faculty orations in many international conferences on Diabetes and Podiatry. He haspublished articles and care reports in some indexed international journals.l

Dr. Rao, M.D, Ph.D, worked as professor of Microbiology, Parasitology, Immunology and Epidemiology in many universities, many medical colleges in India, China, Nepal, Libya, and Philippines. Currently he is working as professor of Microbiology, Parasitology, Immunology and dean of Student Affairs at Avalon University School of Medicine, Curacao, Netherland Antilles. Dr. Rao has more than 44 years of teaching and research experience. Supervised 4 students for Ph.D, degrees in Acharya Nagarjuna University, Guntur, Andhra Pradesh, India . Authored 18 text books. 7 universities honored with fellow ships. Presented 28 full length papers exclusively during 2015 to 2017 in different international journals. Invited Key note speaker for many international ,national conferences, and universities

ReMed was founded in 2009 by Keonie Moore, an experienced naturopath who joined the industry after seeing exceptional results with her sick infant son using natural medicine. Prior to opening ReMed in its original location in Eltham, Keonie ran a successful private practice in Warrandyte as a standalone practitioner.

Mohamed Eddouks is Professor at Moulay Ismail University, Faculty of Sciences and Techniques Errachidia, Morocco. He is a researcher in Physiology and Pharmacology with a Master Degree in Metabolic and Molecular Endocrinology from University of Paris vi, a specialized certificate in Endocrine Pharmacology from University of Paris vii and PhD degrees in Physiology and Pharmacology from University of Liege, Belgium and Sidi Mohammed Ben Abdellah University, Fez, Morocco. After his post-doctoral fellowship at Department of Physiology, Faculty of Medicine of Montreal, Canada, he is working for the last 16 years on medicinal plants. His work on antidiabetic and antihypertensive plants is well recognized globally. His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity and hypertension. His contribution to this field includes four international books and more than 80 peer-reviewed articles and book chapters of international repute. He is Guest Editor of American Journal of Pharmacology and Toxicology, Lead Guest Editor of an annual special issue published by Evidence-Based and Complementary Alternative Medicine, Regional Editor of the Following journals: American Journal of Food Technology, Journal of Applied Sciences, Trends in Applied Sciences Research and Singapore Journal of Scientific research, Member of Editorial Board of several international journals. He has been honored with the first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development and the first Prize of the Federation of Arab Scientific Councils in 2016. He has been the Dean of Polydisciplinary Faculty of Errachidia from 2008 to 2012

Udaya M Kabadi completed General Medicine residency at KEM Hospital and obtained Post-graduate degree (MD) from Mumbai University, Mumbai, India. Hecontinued his Post-graduate training in Internal Medicine and fellowship training in New York, NY, USA. He is Board Certified in Internal Medicine, Endocrinology,Metabolism and Geriatric Medicine by American Board of Internal Medicine. He is a fellow of American College of Physicians, American College of Endocrinologyand Royal College of Physicians of Canada. He is an Adjunct Professor of Medicine at Des Moines University, Des Moines, Iowa and University of Iowa, Iowa,USA. He has authored over 190 papers in peer reviewed medical journals and 2 books. He has conducted over 500 CME presentations and chaired symposia atregional, national and international meetings. He serves as a member of Editorial Board of many medical journals. He has also been elected 'Teacher of the Year'by undergraduate students and post-graduate trainees on several occasions during his career.

Kevin M Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since theinception of the USA in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy.He is the Founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocialand economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.k.galalae@outlook.com

Dr. Sarkar is currently a Distinguished Professor, Departments of Pathology and Oncology at Karmanos Cancer Institute, Wayne State University School of Medicine. Dr. Sarkar’s early research, which still continues, is focused on understanding the role of a “master” transcription factor and the regulation of its upstream and downstream signaling molecules in solid tumors, and focusing on tumor microenvironment. Moreover, his research has been directed toward elucidating the molecular mechanism(s) of action of “natural agents”, their synthetic analogues, and other synthetic small molecule inhibitors of Bcl-2 and MDM2 for cancer prevention and therapy. The discoveries from in vitro and in vivo preclinical studies led to the design and execution of multiple Phase I/II clinical trials in breast, pancreas and prostate cancer for assessing the effects of several “natural agents” in the alterations of biomarkers as well as some early clinical efficacy testing. Dr. Sarkar’s research led to the concept of chemo-sensitization of cancer cells by reversing their drug-resistance phenotype to conventional therapeutics (chemo-radio-therapy), and all of which has been focused on tumor microenvironment, which led to clinical trials conducted at the Karmanos Cancer Institute. The innovation of his basic science research has attracted clinicians to collaborate with him, which clearly documents his leadership in translational research. Dr. Sarkar’s collaborations with basic scientists and physician scientists at MD Anderson Cancer Center led him to become a project leader for the Pancreas Cancer SPORE grant of MD Anderson Cancer Center under the leadership of Dr. James Abbruzzese, and Dr. Sarkar also served as a co-investigator for the University of Michigan Head and Neck Cancer SPORE grant.

Chief of Endocrinology at the VA Medical Center. Supervises fellows in VA Endocrine and Bone clinics. Consult attending for VA several months each year. Serves as a research mentor for fellows.

Dali- Sahi Majda has completed his PhD from Tlemcen university of life sciencesAlgeria. He is the director of research, research Laboratory Molecular Biology and Genetics Health , He has published more than 15 papers in reputed journals and has been serving as 'reviewer.

Dr. Leelavinothan Pari served as Biochemist, during 1989 to 1992 in Annamalai University. He served as a Lecturer in the Department of Biochemistry

Mehmet Emre Atabek has completed his PhD at Erciyes University and Post-doctoral studies at Selcuk University School of Meram Medicine. He is the Director ofPediatric Endocrinology, a premier pediatric endocrinology and diabetology service organization. He has published more than 120 papers in reputed journals andhas been serving as an Editorial Board Member of repute. He has been interested in searching metabolic problems of obese children in most of his articles. Hecontinues to work as Head of Department of Pediatric Endocrinology at Necmettin Erbakan University.

Hamzeh Awad has completed his PhD at the age of 30 years from University of Munich, Germany and worked in disability, rehabilitation, diabetes and eHealth indifferent countries such as Germany and UK. Further he has been appointed as Assistant Prof. at King Saud University, and Research Manager at Prince SultanRehabilitation City, KSA. He is now Associate Prof. in Health Science at Al Khawarizmi International College (KIC), UAE. He has several publications in ISI journalsand Keynote speaker in several international conferences. He has several international collaborations with different research groups. Also, he has been involvedin diabetes research for 10 years and leading Physical therapy work in Diabetes in Middle East.

Virgina School of medicine,Charlottesville, Virginia